Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma

BACKGROUND: Characterization of gene mutation profiles can provide new treatment options for patients with diffuse large B-cell lymphoma (DLBCL). However, this method is challenged by the limited source of tissue specimens, especially those of DLBCL patients at advanced stages. Therefore, in the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Tao, Zhang, Min, Liu, Xiaolan, Li, Jing, Xin, Beibei, Ren, Yanxin, Yang, Yuchao, Wang, Hui, Zhao, Mengjing, Huang, Yunpeng, Guo, Xiaojing, Du, Jun, Qian, Wenbin, Su, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713409/
https://www.ncbi.nlm.nih.gov/pubmed/36465410
http://dx.doi.org/10.3389/fonc.2022.1003957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713409/
https://www.ncbi.nlm.nih.gov/pubmed/36465410
http://dx.doi.org/10.3389/fonc.2022.1003957

Ejemplares similares